Circadian depression subtype identified in large Australian study

Researchers at the University of Sydney identified a subtype of depression associated with the body’s 24-hour circadian rhythm, using clinical and genetic data from more than 10,000 Australians. In the analysis, 2,604 participants—nearly 25% of the study population—were classified as having “circadian depression,” characterized by features including seasonal illness patterns, sleeping longer while depressed, waking with marked fatigue and being a night owl. The findings indicate that circadian features are common among people with severe, recurrent or persistent depression and may distinguish a clinically and genetically different subgroup.

The study used data from the nationwide Australian Genetics of Depression Study and was published in the British Journal of Psychiatry as “Clinical and genetic correlates of a circadian subtype of depression in the Australian Genetics of Depression Study.” Its results apply specifically to participants meeting the study’s criteria for severe, recurrent or persistent depression. They do not establish that nearly one in four people with depression has the subtype, nor do they show that the same proportion would be identified in the wider Australian population. Participants classified with circadian depression were more likely to experience depression at an earlier age and to have more severe symptoms, including mania and higher levels of suicidal thoughts.

They also had higher genetic risk for inflammatory and cardiovascular health problems and for major neurodevelopmental disorders, including attention-deficit hyperactivity disorder. These are associations rather than evidence that circadian disruption caused the additional health risks. The study also reported differences in response to common treatments.

People with the circadian subtype appeared less responsive to serotonin-based antidepressants, including selective serotonin reuptake inhibitors, and experienced more side effects. By contrast, the subgroup appeared more responsive to approaches directed at circadian systems, including melatonin, melatonin-focused antidepressants and light therapy. This pattern supports the proposal that therapies acting on the body clock and its associated brain circuits may be particularly relevant to some patients, although the observational design does not prove that these interventions caused the better responses reported.

First author Dr Emiliana Tonini said the research identified circadian depression in around a quarter of the study population and noted that depression is not a uniform illness. The authors said recognizing clinically distinct subtypes could allow people to access treatments more suited to their condition, particularly at earlier stages of illness. Co-senior author Dr Jacob Crouse said circadian-focused options such as light therapy and melatonin may be more relevant for people showing the features identified in the research, while Professor Ian Hickie emphasized the possible consequences of failing to recognize the presentation early in young people’s illness.

Several features reported in the study make circadian depression potentially recognizable in clinical and research settings. These include a seasonal pattern of illness, longer sleep during depressive periods, waking feeling very tired and a tendency toward being a night owl. The subtype was also associated with earlier onset and more severe symptoms than were seen in other participants.

The findings also carry limitations. The approximately 25% estimate came from a specific cohort of people with severe, recurrent or persistent depression, and the Australian study population should not automatically be treated as representative of every clinical or demographic setting. Treatment-response findings were group-level observations and cannot determine an individual patient’s response.

Likewise, the higher genetic risks for cardiovascular, inflammatory and neurodevelopmental conditions describe associations within the study and do not mean that a person classified with circadian depression will develop those conditions. Overall, the research offers a biologically informed account of heterogeneity within depression. It links a recognizable pattern of sleep, seasonal and chronotype features with earlier onset, greater symptom severity, distinct genetic risks and different reported responses to serotonin-based and circadian-focused treatments.

Subject of Research: Clinical and genetic correlates of circadian depression in the Australian Genetics of Depression Study

Article Title: Researchers identify new “circadian” subtype of depression

Article References: Researchers identify new “circadian” subtype of depression. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: circadian depression, depression subtypes, circadian rhythm, genetic analysis, sleep patterns, antidepressant response, melatonin, light therapy, Australian study, psychiatry, Researchers, identify